Non-cardiovascular non-obstetric surgery in pre-capillary pulmonary hypertension at a single center in Japan

Non-cardiovascular non-obstetric surgery in pre-capillary pulmonary hypertension at a single center in Japan

Background: Recently, the survival outcome of precapillary pulmonary hypertension (pc-PH) has been remarkably improved, with the progress of treatment options. Hence, the number of non-cardiovascular, non-obstetric surgeries for patients with pc-PH will be expected to...
Επιτυχής νέα συνεδρία BPA σοβαρού περιστατικού

Επιτυχής νέα συνεδρία BPA σοβαρού περιστατικού

Μέσα στον περασμένο μήνα στα πλαίσια του προγράμματος BPA (αγγειοπλαστική με μπαλονάκι στην πνευμονική αρτηρία), είχαμε τη χαρά να υποδεχτούμε ξανά τον καθηγητή κο Hiromi Matsubara από την Ιαπωνία. Το πρόγραμμα αυτό εκπόνησε και υλοποίησε ο σύλλογός μας τον Δεκέμβριο...
Acute hemodynamic improvement in chronic pulmonary arterial hypertension on dual therapy following RT234 inhalation

Acute hemodynamic improvement in chronic pulmonary arterial hypertension on dual therapy following RT234 inhalation

RT234 is an inhaled formulation of the phosphodiesterase type-5 inhibitor (PDE5i) vardenafil, in development for episodic symptoms of pulmonary arterial hypertension (PAH). This phase 2a escalating-dose trial evaluated acute changes in pulmonary vascular resistance...
Inhaled iloprost improves right ventricular load-independent contractility in pulmonary hypertension

Inhaled iloprost improves right ventricular load-independent contractility in pulmonary hypertension

Background: The adaptation of the right ventricular contractility to its afterload (RV–PA coupling), best measured by the ratio of end-systolic elastance (Ees) and arterial elastance (Ea), is a key determinant for prognosis and symptomatology in pulmonary hypertension...
Translate »

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!